A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
about
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patientsFluid biopsy for solid tumors: a patient's companion for lifelong characterization of their diseaseMetastatic cancer stem cells: from the concept to therapeuticsMinimal residual disease and circulating tumor cells in breast cancerImmune humanization of immunodeficient mice using diagnostic bone marrow aspirates from carcinoma patientsTracing the origin of disseminated tumor cells in breast cancer using single-cell sequencingEffect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.Clinical relevance and current challenges of research on disseminating tumor cells in cancer patientsClinical impact of different detection methods for disseminated tumor cells in bone marrow of patients undergoing surgical resection of colorectal liver metastases: a prospective follow-up study.Early dissemination seeds metastasis in breast cancer.Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trial.Cytokeratin-positive cells in the bone marrow of breast cancer patients and noncancer donorsCirculating tumor cells, disease recurrence and survival in newly diagnosed breast cancerPrognostic relevance of induced and spontaneous apoptosis of disseminated tumor cells in primary breast cancer patients.Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic PatientsGene expression profile of circulating tumor cells in breast cancer by RT-qPCR.Persistent tumor cells in bone marrow of non-metastatic breast cancer patients after primary surgery are associated with inferior outcome.LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival.Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patientsDisseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention studyDisseminated tumour cells as a prognostic biomarker in colorectal cancerPGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasisPresence of apoptotic and nonapoptotic disseminated tumor cells reflects the response to neoadjuvant systemic therapy in breast cancer.Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trialEnrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cellsMetastasis: recent discoveries and novel treatment strategies.Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer.Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer PatientsHeterogeneity of ERα and ErbB2 Status in Cell Lines and Circulating Tumor Cells of Metastatic Breast Cancer Patients.Bone marrow micrometastases in early breast cancer-30-year outcome.Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapyCXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer.Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues.Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevanceCirculating tumor cells: detection, molecular profiling and future prospects.Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic diseaseERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients.Analysis of disseminated tumor cells before and after platinum based chemotherapy in primary ovarian cancer. Do stem cell like cells predict prognosis?
P2860
Q21284707-FAD5C448-9931-4712-8E36-73C370B58A4EQ24623374-5F66A93F-D418-4308-B893-592E0499EB62Q26850739-2AE286B5-E122-43BD-9D3F-B2287F3BEFCCQ27010152-7AD540F7-8103-4EDE-BCD2-3222B4D9AAF5Q27331362-24F74E17-43CD-4FAE-9470-4756D951EBEFQ28396153-17B29A20-909D-4608-9C0B-12A8D8BFFBB6Q30416847-67A33342-836A-4934-A3C8-5D2330DC6BA3Q33555492-CBEE7378-EB9E-4D61-B699-0D85C6C4E7A0Q33560473-A051D13D-BF7B-4BB3-8C30-A4A108D210F6Q33562263-ADEEF9DE-5121-4F22-ABB6-449EC77E72F9Q33587199-E0B5EE0D-1BDD-49D1-8BE4-4DBD1DEFB4F6Q33718843-E15FC0F0-9243-49B4-BF82-06C4378BEDE0Q33739272-F6F08ECB-1FCB-452E-BFD5-45B1E31159AEQ33746929-3FC9DD75-BD1F-49D4-9C68-18D8FF61B25DQ33839150-F0F91530-4D81-4088-8DBD-06A3AAC74D6BQ34038793-5EB618B0-B80A-4CF1-A856-D0824E2565C7Q34284264-A405CEDF-A76D-47CB-AB4B-EEC70E375D7AQ34360216-6CCA1C52-3D44-4A83-9364-59C66DF707B1Q34468675-AE6F506F-A846-437E-9C3B-E52A38A76F7AQ34520174-1EDE9212-EB44-4B97-9144-81E13EA331ECQ35006944-23BF384C-1656-419D-BC64-318FD34E7DF7Q35204528-563B1C42-3FDE-430E-B840-FB6B18BA4F4AQ35605856-551FA428-8129-4E91-9215-B5AD795EC590Q36069885-390AD7C5-24E2-4A3A-A44A-CE6DD2C6FE72Q36262506-DF32D8FA-6822-4590-8E24-C76F4F455F91Q36369695-79FC25BE-44F7-451D-AFBF-7D8AFE4EE379Q36393149-6DA31276-5093-41E8-8987-291393C19C52Q36407511-6118ED88-9978-48D8-A4BD-4F1D2F1D222FQ36427515-E6512E90-612E-44FC-9857-537838014955Q36482582-7FEE4D5F-B487-43A2-A8E1-62E023E21AC4Q36525788-429E5EDE-6C55-461D-A2CE-E787AF7F57BBQ36547904-5107CA35-919C-4891-A208-BC337D84947FQ36574920-4E9D0E89-B8DC-4B85-82E9-45C78D489664Q36668951-93CA220D-0530-491A-A818-B202577EBC3CQ36930838-EAF9FF8B-8C57-4211-AE7E-55BBD1C39ACCQ37019257-F8D2AC0C-AAB7-43D9-A1ED-3B6C4B32A522Q37027492-B34BAC97-A292-4D64-874F-8AC05880C244Q37036125-B7674B2B-34F7-4130-B0F0-E43C8E6F6A91Q37038635-CD2ACF74-1894-41FA-AF46-02BACE568762Q37295702-D0759AF3-8F0D-42A8-B33D-2C36A0C77731
P2860
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A concept for the standardized ...... d its clinical implementation.
@ast
A concept for the standardized ...... d its clinical implementation.
@en
type
label
A concept for the standardized ...... d its clinical implementation.
@ast
A concept for the standardized ...... d its clinical implementation.
@en
prefLabel
A concept for the standardized ...... d its clinical implementation.
@ast
A concept for the standardized ...... d its clinical implementation.
@en
P2093
P50
P356
P1433
P1476
A concept for the standardized ...... d its clinical implementation.
@en
P2093
Christian Marth
Christian Schindlbeck
Erich Solomayer
Gerhard Gebauer
Klaus Pantel
Stephan Braun
Volkmar Muller
Wolfgang Janni
P304
P356
10.1002/CNCR.22076
P407
P577
2006-09-01T00:00:00Z